Related Experiment Video
Updated: Jan 18, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Antiphospholipid Antibodies as Potential Prognostic Indicators of Recurrent Myocardial Infarction
Autoimmune markers like antiphospholipid antibodies (aPLs) combined with antinuclear antibodies (ANA)/anti-extractable nuclear antigen antibodies (anti-ENA) predict recurrent myocardial infarction (MI) and mortality in patients. This highlights the prognostic impact of autoimmune dysregulation on MI outcomes.
Area of Science:
- Cardiology
- Immunology
- Autoimmunity
Background:
- Inflammation and autoimmunity are key factors in myocardial infarction (MI) risk.
- Emerging research links autoimmune disorders to MI pathogenesis.
- This study investigates the prognostic value of specific autoantibodies in recurrent MI.
Purpose of the Study:
- To assess the impact of antiphospholipid antibodies (aPLs), antinuclear antibodies (ANA), and anti-ENA on recurrent MI risk.
- To identify autoantibody profiles associated with adverse cardiovascular outcomes.
- To elucidate the role of autoimmune dysregulation in MI prognosis.
Main Methods:
- A prospective cohort study of 458 acute MI (AMI) patients followed for 3 years.
- Assessed autoantibody profiles including aPLs (ACA, anti-β2GPI, LA), ANA, and anti-ENA.
- Compared autoantibody positivity between recurrent and non-recurrent AMI groups, monitoring mortality and recurrence at 3, 12, and 36 months.
Main Results:
- Recurrent AMI patients showed higher positivity rates for ACA IgG/IgM, anti-β2GPI IgG/IgM, and aPLs + ANA/anti-ENA.
- Concurrent aPLs + ANA/anti-ENA positivity was an independent risk factor for AMI recurrence (HR: 2.84).
- Hypertension and hyperlipidemia were also independent risk factors for AMI recurrence.
Conclusions:
- Concurrent aPLs and ANA/anti-ENA positivity is an independent predictor of recurrent AMI.
- This autoantibody profile is associated with increased mortality in AMI patients.
- Autoimmune dysregulation significantly impacts MI patient outcomes, underscoring its prognostic importance.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Myocarditis III: Medical Management
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...